Company Filing History:
1 out of 1 
1 out of 13 
Years Active: 2007
Title: Caroline Bonneau: Innovator in Nucleic Acid Research
Introduction
Caroline Bonneau is a notable inventor based in Rouen, France. She has made significant contributions to the field of molecular biology, particularly in the area of allergen research. Her work has led to the development of innovative solutions that address important health concerns.
Latest Patents
Caroline holds 1 patent for a purified nucleic acid molecule. This patent comprises a nucleotide sequence coding for allergen Dac g5, which has the amino acid sequence SEQ ID NO. 2, along with its derivatives or fragments. This invention showcases her expertise in genetic research and its applications in allergy treatment.
Career Highlights
Throughout her career, Caroline has worked with prominent companies in the pharmaceutical and biotechnology sectors. She has been associated with Seita Groupe Altadis and Stallergenes, where she has contributed to various research initiatives and product developments. Her experience in these organizations has helped her refine her skills and expand her knowledge in the field.
Collaborations
Caroline has collaborated with esteemed professionals in her field, including Ronald Van Ree and Erica Van Oort. These partnerships have allowed her to engage in meaningful research and contribute to advancements in allergen science.
Conclusion
Caroline Bonneau is a distinguished inventor whose work in nucleic acid research has made a significant impact on allergy treatment. Her innovative patent and collaborations with industry leaders highlight her dedication to advancing scientific knowledge.